Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Public Health
Published in: Journal of Public Health 2/2014

01-04-2014 | Original Article

Initial anticoagulation therapy in patients with venous thromboembolism and impaired renal function: results of an observational study

Authors: Bjoern Boettger, Martin Wehling, Rupert M. Bauersachs, Steffen Amann, Thomas Wilke

Published in: Journal of Public Health | Issue 2/2014

Login to get access

Abstract

Aim

Patients undergoing initial therapeutic anticoagulation after a venous thromboembolic event (VTE) with severely impaired renal function (RI-VTE-patients) are at high risk of accumulating the anticoagulants resulting in an increased risk of bleeding events. Current guidelines/approved summary of product characteristics (SPC) recommend usage of specific anticoagulants only, monitoring of aXa-activity, and/or dose adjustment (in the case of enoxaparin) for initial therapeutic anticoagulation of RI-VTE patients. This study investigates the treatment of German RI-VTE-patients and evaluates whether guideline/SPC recommendations are implemented in the practice of real life care.

Subjects and methods

We conducted a chart review in five German acute hospitals. All VTE patients treated in these hospitals from 01/01/2007–31/12/2011 were included. Renal insufficiency (RI) was defined as CrCl < 30 ml/min. Treatment did not conform to the recommendations in guidelines/SPCs, if (1) a drug was used that is contraindicated according to the SPC or no initial anticoagulation treatment was implemented at all; (2) the recorded daily dose of enoxaparin was higher than the recommended weight-adjusted dose.

Results

Of 5,263 VTE patients identified, 709 (13.5 %) cases could not be documented due to missing charts (601) or no documented creatinine serum levels (108). Of the remaining 4,554 patients (mean age ±SD 67.4 years ±15.7; 53.0 % female; weight 80.2 kg ±20.0; 54.5 % deep VT), 337 (7.4 %) had a mean estimated GFR < 30 ml/min. In 19 (5.6 %) of these cases, patients were treated with a drug not recommended for use, 21 (6.2 %) did not receive any initial anticoagulation treatment and 91 (27.0 %) received a higher than recommended dosage of enoxaparin. Additionally, for 22 patients (6.5 %) receiving enoxaparin, no weight information was recorded and it is therefore unlikely that the dosage was adjusted correctly.

Conclusion

VTE treatment in RI-VTE-patients differs remarkably from labelled recommendations; over-dosage of enoxaparin is common. It seems fair to assume that these patients face a higher risk of adverse reactions, in particular bleeding events.
Literature
Al Dieri R, Alban S, Béguin S, Hemker HC (2006) Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight. J Thromb Haemost 4(1):83–89PubMedCrossRef
Barras MA, Duffull SB, Atherton JJ, Green B (2008) Individualized compared with conventional dosing of Enoxaparin. Clin Pharmacol Ther 83(6):882–888PubMedCrossRef
Barras MA, Duffull SB, Atherton JJ, Green B (2010a) Individualized dosing of Enoxaparin for subjects with renal impairment is superior to conventional dosing at achieving therapeutic concentrations. Ther Drug Monit 32(4):482–488PubMedCrossRef
Barras MA, Kirkpatrick CM, Green B (2010b) Current dosing of low-molecular-weight heparins does not reflect licensed product labels: an international survey. Br J Clin Pharmacol 69(5):520–528PubMedCentralPubMedCrossRef
Bauersachs R, Schellong SM, Haas S, Tebbe U, Gerlach HE, Abletshauser C, Sieder C, Melzer N, Bramlage P, Riess H (2011) CERTIFY: prophylaxis of venous thromboembolism in patients with severe renal insufficiency. Thromb Haemost 105(6):981–988PubMedCrossRef
Blix HS, Viktil KK, Moger TA, Reikvam A (2006) Use of renal risk drugs in hospitalized patients with impaired renal function: an underestimated problem? Nephrol Dial Transplant 21(11):3164–3171PubMedCrossRef
Bueller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, Segers AE, Cariou R, Leeuwenkamp O, Lensing AW (2004) Fondaparinux or Enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. Ann Intern Med 140:867–873CrossRef
Cenik BK, Sun H, Gerber DE (2013) Impact of renal function on treatment options and outcomes in advanced non-small cell lung cancer. Lung Cancer 80(3):326–332CrossRef
Clegg LX, Potosky AL, Harlan LC, Hankey BF, Hoffman RM, Stanford JL, Hamilton AS (2001) Comparison of self-reported initial treatment with medical records for the Prostate Outcomes Study. Am J Epidermiol 154:582–587CrossRef
Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31–41PubMedCrossRef
Cook D, Douketis J, Meade M, Guyatt G, Zytaruk N, Granton J, Skrobik Y, Albert M, Fowler R, Hebert P, Pagliarello G, Friedrich J, Freitag A, Karachi T, Rabbat C, Heels-Ansdell D, Geerts W, Crowther M, Group CCCT (2008) Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors. Crit Care 12(2):R32PubMedCentralPubMedCrossRef
Crowther M, Lim W (2007) Low molecular weight heparin and bleeding in patients with chronic renal failure. Curr Opin Pulm Med 13(5):409–413PubMed
Deutsche Gesellschaft für Angiologie (DGA), Dt. Ges. für Chirurgie (DGCh), der Dt. Ges. für Gefäßchirurgie (DGG), der Dt. Ges. für Gynäkologie und Geburtshilfe (DGGG), der Dt. Ges. für Hämatologie und Onkologie (DGHO), der Dt. Ges. für Internistische Intensivmedizin und Notfallmedizin (DGIIN), der Dt. Ges. für Kardiologie (DGK), der Dt. Ges. für Phlebologie (DGP), der Dt. Ges. für Pneumologie und Beatmungsmedizin (DGP), der Dt. Röntgengesellschaft (DRG), der Dt. Ges. für Thrombose und Hämostase (GTH) und der Dt. Ges. für Ultraschall in der Medizin (DEGUM) (2010) Diagnostik und Therapie der Venenthrombose und der Lungenembolie. AWMF-Leitlinien-Register Nr. 065/002. Stand 06/2010. http://​www.​awmf.​org/​uploads/​tx_​szleitlinien/​065-002_​S2_​Diagnostik_​und_​Therapie_​der_​Venenthrombose_​und_​der_​Lungenembolie_​06-2010_​2_​.​pdf. Accessed 19 June 2013
Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schünemann HJ, American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel (2012) Executive summary: antithrombotic therapy and prevention of thrombosis, 9th edn. American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):7S–47SPubMedCentralPubMedCrossRef
Hoffmann P, Keller F (2012) Increased major bleeding risk in patients with kidney dysfunction receiving Enoxaparin: a meta-analysis. Eur J Clin Pharmacol 68(5):757–765PubMedCrossRef
Holweger K, Bokemeyer C, Lipp HP (2005) Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge. J Cancer Res Clin Oncol 131:559–567PubMedCrossRef
Kaneva K, Bansal V, Hoppensteadt D, Cunanan J, Fareed J (2013) Variations in the circulating heparin levels during maintenance hemodialysis in patients with end-stage renal disease. Clin Appl Thromb Hemost 19(4):449–452PubMedCrossRef
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR (2012) Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th edn. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e419S–e494SPubMedCentralPubMed
Kravitz MS, Mishaal RA, Shoenfeld Y (2005) Renal failure and low molecular weight heparins: a dangerous liaison? The case of retroperitoneal hematoma. Isr Med Assoc J 7(9):600–601PubMed
Kubitza D, Becka M, Mueck W, Halabi A, Maatouk H, Klause N, Lufft V, Wand DD, Philipp T, Bruck H (2010) Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor. Br J Clin Pharmacol 70(5):703–712PubMedCentralPubMedCrossRef
Lensing AW, Prins MH, Davidson BL, Hirsh J (1995) Treatment of deep venous thrombosis with low-molecular-weight heparins: a meta-analysis. Arch Intern Med 155(6):601–607PubMedCrossRef
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation—modification of diet in renal disease study group. Ann Intern Med 130:461–470PubMedCrossRef
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612PubMedCentralPubMedCrossRef
Lim W (2008) Low-molecular-weight heparin in patients with chronic renal insufficiency. Intern Emerg Med 3(4):319–323PubMedCrossRef
Lim W, Dentali F, Eikelboom JW, Crowther MA (2006a) Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 144(9):673–684PubMedCrossRef
Lim WH, Lim EM, McDonald S (2006b) Lean body mass-adjusted Cockcroft and Gault formula improves the estimation of glomerular filtration rate in subjects with normal-range serum creatinine. Nephrology (Carlton) 11(3):250–256CrossRef
Limdi NA, Limdi MA, Cavallari L, Anderson AM, Crowley MR, Baird MF, Allon M, Beasley TM (2010) Warfarin dosing in patients with impaired kidney function. Am J Kidney Dis 56(5):823–831PubMedCentralPubMedCrossRef
Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT (2010) Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 5(6):1003–1009PubMedCentralPubMedCrossRef
Monreal M, Falgá C, Valle R, Barba R, Bosco J, Beato JL, Maestre A, Investigators RIETE (2006) Venous thromboembolism in patients with renal insufficiency: findings from the RIETE Registry. Am J Med 119(12):1073–1079PubMedCrossRef
Nagge J, Crowther M, Hirsh J (2002) Is impaired renal function a contraindication to the use of low-molecular-weight heparin? Arch Intern Med 162(22):2605–2609PubMedCrossRef
Nicolaides A, Hull RD, Fareed J (2013) Prevention and treatment of venous thromboembolism: international consensus statement (guidelines according to scientific evidence). Clin Appl Thromb Hemost 19(2):116–118CrossRef
Riess H, Koppenhagen K, Tolle A, Kemkes-Matthes B, Grave M, Patek F, Drexler M, Siemens HJ, Harenberg J, Weidinger G, Brom J, Haas S (2003) Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis. Thromb Haemost 90:252–259PubMed
Salomon L, Deray G, Jaudon MC, Chebassier C, Bossi P, Launay-Vacher V, Diquet B, Ceza JM, Levu S, Brücker G, Ravaud P (2003) Medication misuse in hospitalized patients with renal impairment. Int J Qual Health Care 15(4):331–335PubMedCrossRef
Schmid P, Fischer AG, Wuillemin WA (2009) Low-molecular-weight heparin in patients with renal insufficiency. Swiss Med Wkly 139(31–32):438–452
Schulman S, Beyth RJ, Kearon C, Levine MN (2008) Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians evidence-based clinical practice guidelines, 8th edn. Chest 133:257S–298SPubMedCrossRef
Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, Gore JM, Goldberg RJ (2009) Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism: The Worcester VTE study. J Thromb Thrombolysis 28(4):401–409PubMedCentralPubMedCrossRef
Thorevska N, Amoateng-Adjepong Y, Sabahi R, Schiopescu I, Salloum A, Muralidharan V, Manthous CA (2004) Anticoagulation in hospitalized patients with renal insufficiency: a comparison of bleeding rates with unfractionated heparin vs enoxaparin. Chest 125(3):856–863PubMedCrossRef
Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galiè N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D, Janssens U, Klepetko W, Mayer E, Remy-Jardin M, Bassand JP, ESC Committee for Practice Guidelines (CPG) (2008) Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29(18):2276–2315PubMedCrossRef
van den Belt AG, Prins MH, Lensing AW, Castro AA, Clark OA, Atallah AN, Burihan E (2000) Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2000(2):CD001100
van Dongen CJ, van den Belt AG, Prins MH, Lensing AW (2004) Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2004(4):CD001100
Metadata
Title
Initial anticoagulation therapy in patients with venous thromboembolism and impaired renal function: results of an observational study
Authors
Bjoern Boettger
Martin Wehling
Rupert M. Bauersachs
Steffen Amann
Thomas Wilke
Publication date
01-04-2014
Publisher
Springer Berlin Heidelberg
Published in
Journal of Public Health / Issue 2/2014
Print ISSN: 2198-1833
Electronic ISSN: 1613-2238
DOI
https://doi.org/10.1007/s10389-013-0598-z

Other articles of this Issue 2/2014

Journal of Public Health 2/2014 Go to the issue

Original Article

“Human trafficking, public health and the law”: a comprehensive analysis of intersections

Original Article

A comparative analysis of TLR5 polymorphism and clinical parameters in typhoid patients and asymptomatic typhoid carriers

Original Article

Long-term efficacy of an attachment-based parental training program for single mothers and their children: a randomized controlled trial

Editorial

Our 21st century health identity: Where is sleep?

Original Article

Multiple behavioral risk factors for chronic diseases in adults aged 50+: regional differences across eleven European countries

Original Article

Social and health related risk factors for low cardio respiratory fitness in German adolescents: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)